1-1 of 1
Parul Hazarika
Close
Sort by
Journal Articles

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Clinical Trials & Observations
Madeleine Duvic, Rakshandra Talpur, Xiao Ni, Chunlei Zhang, Parul Hazarika, Cecilia Kelly, Judy H. Chiao, John F. Reilly, Justin L. Ricker, Victoria M. Richon, Stanley R. Frankel
Journal: Blood
Blood (2006) 109 (1): 31–39.
https://doi.org/10.1182/blood-2006-06-025999
Published: 2006